Cargando…
Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
BACKGROUND: The Stockholm III Trial randomized patients with primary operable rectal cancers to either short‐course radiotherapy (RT) with immediate surgery (SRT), short‐course RT with surgery delayed 4–8 weeks (SRT‐delay) or long‐course RT with surgery delayed 4–8 weeks. This preplanned interim ana...
Autores principales: | Pettersson, D., Lörinc, E., Holm, T., Iversen, H., Cedermark, B., Glimelius, B., Martling, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744683/ https://www.ncbi.nlm.nih.gov/pubmed/26095256 http://dx.doi.org/10.1002/bjs.9811 |
Ejemplares similares
-
Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
por: Erlandsson, Johan, et al.
Publicado: (2022) -
Organ preservation following short-course radiotherapy for rectal cancer
por: Nilsson, Per J, et al.
Publicado: (2021) -
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2017) -
On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery
por: Glimelius, Bengt
Publicado: (2017) -
Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?
por: Glimelius, Bengt
Publicado: (2014)